OBJECTIVE: To estimate whether continuous oral contraceptive pills (OCPs) will result in
more pain relief in primary dysmenorrhea patients than cyclic OCPs, which induce …

Context: Continuous oral contraception may better suppress the ovary and endometrium,
lending itself to the treatment of other medical conditions. Objective: Our objective was to …

Objectives: The aim of the study was to examine, in a sample of Italian women, the rate of
discontinuation of use of hormonal contraception. Methods: In a retrospective cross …

Hypertension is a major risk factor for cardiovascular diseases. Because of the high
frequency of hormonal contraceptives use, assessing their side effects is an important public …

Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and
potent testosterone-derived progestins, developed in order to improve general and vascular …

Objective To determine the effectiveness of a 24/4-day regimen of a low-dose combination
drospirenone–ethinylestradiol oral contraceptive in alleviating perimenstrual symptoms …

Background Body mass index (BMI) may influence ovulation inhibition resulting from
transdermal hormone delivery. Investigation of this effect is important given the high …

Objective: To determine the relative bioavailability of ethinyl estradiol (EE) and gestodene
(GSD) after application of a novel transdermal contraceptive patch vs. a standard combined …

This Phase III, uncontrolled, open-label, multicenter study was conducted to investigate the
contraceptive efficacy, bleeding pattern, and cycle control of a novel once-a-week …

Objective (s) The aim of this study was to investigate the bleeding pattern and cycle control
of a contraceptive patch containing 0.55 mg ethinyl estradiol (EE) and 2.1 mg gestodene …